Enzyme presents drug target to rare lung disease

An enzyme called Src kinase may provide a new way to attack lymphangioleiomyomatosis (LAM), a rare lung disease that appears only in women either alone or in association with a genetic disorder known as tuberous sclerosis, said researchers from Baylor College of Medicine in a report that appears in the journal Cancer Research.

Read the full press release here: https://www.bcm.edu/news/cancer/enzyme-drug-target-for-rare-lung-disease

Read the news article: http://bionews-tx.com/news/2014/04/03/bcm-finds-new-drug-target-for-lymphangioleimyomatosis/